These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
20 related articles for article (PubMed ID: 3416554)
1. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review. Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613 [TBL] [Abstract][Full Text] [Related]
2. Microevolution in lower Central America: genetic characterization of the Chibcha-speaking groups of Costa Rica and Panama, and a consensus taxonomy based on genetic and linguistic affinity. Barrantes R; Smouse PE; Mohrenweiser HW; Gershowitz H; Azofeifa J; Arias TD; Neel JV Am J Hum Genet; 1990 Jan; 46(1):63-84. PubMed ID: 2294755 [TBL] [Abstract][Full Text] [Related]
3. Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama. Jorge LF; Arias TD; Inaba T; Jackson PR Br J Clin Pharmacol; 1990 Aug; 30(2):281-5. PubMed ID: 2206790 [TBL] [Abstract][Full Text] [Related]
4. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers. Arias TD; Jorge LF; Lee D; Barrantes R; Inaba T Clin Pharmacol Ther; 1988 Apr; 43(4):456-65. PubMed ID: 3356089 [TBL] [Abstract][Full Text] [Related]
5. An observation on the ethnic uniqueness of the debrisoquine and sparteine antimodes: a study in the Ngawbé Guaymí Amerindians of Panamá. Arias TD; Jorge LF Br J Clin Pharmacol; 1989 Oct; 28(4):493-4. PubMed ID: 2590609 [No Abstract] [Full Text] [Related]
6. [Population pharmacology and ethnopharmacokinetics in 3 Amerindian groups from Panama: Cuna, Ngawbe Guaymi and Teribe]. Arias TD; Jorge LF Rev Med Panama; 1990 Jan; 15(1):20-6. PubMed ID: 2330419 [TBL] [Abstract][Full Text] [Related]
7. Evolutionary pharmacogenetics of CYP2D6 in Ngawbe Guaymi of Panama: allele-specific PCR detection of the CYP2D6B allele and RFLP analysis. Jorge LF; Arias TD; Griese U; Nebert DW; Eichelbaum M Pharmacogenetics; 1993 Oct; 3(5):231-8. PubMed ID: 7904509 [TBL] [Abstract][Full Text] [Related]
8. Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama. Petersen DD; Kong AN; Jorge LF; Nebert DW; Arias TD Pharmacogenetics; 1991 Dec; 1(3):136-42. PubMed ID: 1688244 [TBL] [Abstract][Full Text] [Related]
9. Polymorphic oxidation of debrisoquine and sparteine. Eichelbaum M Prog Clin Biol Res; 1986; 214():157-67. PubMed ID: 3523506 [No Abstract] [Full Text] [Related]
10. A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway. Arias TD; Inaba T; Cooke RG; Jorge LF Clin Pharmacol Ther; 1988 Sep; 44(3):343-52. PubMed ID: 3416554 [TBL] [Abstract][Full Text] [Related]